Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. The TRADE-AIS Study
TRADE-AIS
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
This prospective observational study aims to determine whether specific parameters measured by transcranial Doppler ultrasound (TCD) can predict clinical outcomes in patients with acute ischemic stroke (AIS). The primary objective is to evaluate the association between middle cerebral artery (MCA) flow velocities and short-term neurological improvement. Secondary outcomes include the presence of collateral flow and flow patterns in relation to functional recovery measured by NIHSS and modified Rankin Scale (mRS) scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Aug 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 27, 2025
CompletedFirst Posted
Study publicly available on registry
June 4, 2025
CompletedStudy Start
First participant enrolled
August 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2027
Study Completion
Last participant's last visit for all outcomes
August 30, 2027
September 16, 2025
September 1, 2025
12 months
May 27, 2025
September 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in NIHSS score from baseline to 72 hours
Neurological status will be assessed using the National Institutes of Health Stroke Scale (NIHSS) at baseline (upon admission) and again at 72 hours. The primary objective is to evaluate the correlation between initial transcranial Doppler (TCD) measurements-specifically, mean flow velocity and pulsatility index in the middle cerebral artery-and the degree of clinical improvement or deterioration, as reflected by changes in NIHSS score. A greater reduction in NIHSS score indicates better neurological recovery. The NIH Stroke Scale (NIHSS) is a standardized, 15-item clinical assessment tool used to evaluate the severity of neurologic deficits in patients with acute stroke. The total NIHSS score ranges from 0 to 42, where: 0 = no stroke symptoms Higher scores indicate greater stroke severity and worse neurological outcomes The scale includes assessments of level of consciousness, gaze, visual fields, motor strength, limb ataxia, sensory function, language, and neglect.
72 hours
Secondary Outcomes (2)
Presence of collateral circulation associated with ≥ 4-point NIHSS improvement
7 days
Functional status at discharge (modified Rankin Scale)
At hospital discharge (within 14 days of admission)
Study Arms (1)
Inpatient Stroke confirmed
OTHERAll participants diagnosed with acute ischemic stroke will undergo standard clinical evaluation and transcranial Doppler ultrasound within 24 hours of symptom onset. No interventions are assigned by the study. Clinical and hemodynamic data will be collected to assess prognostic associations with short-term outcomes. All patients are managed according to routine care protocols determined by the attending medical team.
Interventions
A non-invasive bedside diagnostic procedure used to measure cerebral blood flow velocities and pulsatility index in intracranial arteries, primarily the middle cerebral artery (MCA). The test is performed within the first 24 hours of symptom onset using standard ultrasound equipment with a 2-MHz probe. The data collected is used solely for prognostic evaluation and does not influence treatment decisions.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Clinical diagnosis of acute ischemic stroke
- Onset of symptoms ≤ 24 hours before admission
- Underwent or will undergo transcranial Doppler ultrasound within 24 hours of symptom onset
- Able to provide informed consent or consent obtained from a legal representative
You may not qualify if:
- Evidence of intracerebral hemorrhage on imaging
- Inadequate temporal acoustic window for transcranial Doppler
- Intubated or hemodynamically unstable prior to Doppler evaluation
- Known diagnosis of neurodegenerative disease significantly affecting baseline neurological function (e.g., advanced dementia, Parkinson's disease)
- Refusal to participate or withdrawal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY, Koroshetz WJ, Kaps M, Tegeler CH; American Society of Neuroimaging Practice Guidelines Committee. Practice standards for transcranial Doppler ultrasound: part I--test performance. J Neuroimaging. 2007 Jan;17(1):11-8. doi: 10.1111/j.1552-6569.2006.00088.x.
PMID: 17238867BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Crit Care sp
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Research and Medical Education Clinica Mexico
Study Record Dates
First Submitted
May 27, 2025
First Posted
June 4, 2025
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
July 31, 2027
Study Completion (Estimated)
August 30, 2027
Last Updated
September 16, 2025
Record last verified: 2025-09